A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

Cell

Volumn 70, Issue 4, 1992, Pages 539-551

  Liu, Yongjian ^a   Peter, Doris ^a   Roghani, Ali ^a   Schuldiner, Shimon ^b   Prive, Gilbert G ^a   Eisenberg, David ^a   Brecha, Nicholas ^a,c   Edwards, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; COCAINE; COMPLEMENTARY DNA; RESERPINE; TETRABENAZINE;

AMINE TRANSPORT; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DRUG RESISTANCE; GENE EXPRESSION; GENE TRANSFER; MEMBRANE TRANSPORT; MOLECULAR CLONING; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

1-METHYL-4-PHENYLPYRIDINIUM; ADRENAL GLANDS; AMINES; AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BIOLOGICAL TRANSPORT; BRAIN CHEMISTRY; CHO CELLS; CLONING, MOLECULAR; DNA; HAMSTERS; METABOLIC DETOXICATION, DRUG; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RATS; SEQUENCE ALIGNMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0026713852     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90425-C     Document Type: Article

References (86)

1. 3H-acetylcholine by Torpedo electric organ synaptic vesicles
2. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles
3. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose
4. 3H-norepinephrine by tissues
5. Cloning and expression of a functional serotonin transporter from rat brain
6. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
7. GABA and glycine in synaptic vesicles: storage and transport characteristics
8. Lac permease of Escherichia coli: topology and sequence elements promoting membrane insertion
9. Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system
10. ++-ATP-dependent storage mechanism in the amine granules of the adrenal medulla
11. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
12. Uptake of glycine into synaptic vesicles isolated from rat spinal cord
13. Monoamine oxidase and oxidative stress at dopaminergic synapses
14. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes
15. Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter
16. Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter
17. Pathways to regulated exocytosis in neurons
18. An improved approach to histofluorescence using the SPG method for tissue monoamines
19. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
20. A comprehensive set of sequence analysis programs for the VAX
21. High efficiency transformation of E. coli by high voltage electroporation
22. Analysis of membrane and surface protein sequences with the hydrophobic moment plot
23. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
24. Structure and function of vacuolar class of ATP-driven proton pumps
25. Mental depression in hypertensive patients treated for long periods with high doses of reserpine
26. Uptake of γ-aminobutyric acid by a synaptic vesicle fraction isolated from rat brain
27. Cloning and functional characterization of a cocaine-sensitive dopamine transporter
28. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells
29. Profile analysis: detection of distantly related proteins
30. Cloning and expression of a rat brain GABA transporter
31. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
32. Uptake of GABA by rat brain synaptic vesicles isolated by a new procedure
33. Cloning of a serotonin transporter affected by antidepressants
34. Distributional maps of tyrosine hydroxylase-immunoreactive neurons in the rat brain
35. Characterization and purification of the monoamine transporter of bovine chromaffin granules
36. The uptake of biogenic amines
37. Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
38. Current concepts. IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
39. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport
40. β-galactoside transport in E. coli: a functional dissection of lac permease
41. Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli
42. Mechanism of storage and transport of neurotransmitters
43. Secretory granule and synaptic vesicle formation
44. Cloning and expression of a cocaine-sensitive rat dopamine transporter
45. Uptake of catecholamines by a particulate fraction of the adrenal medulla
46. Active transport of γ-aminobutyric acid and glycine into synaptic vesicles
47. Identification of catecholamine and luteinizing hormone-releasing hormone (LHRH)-containing neurons in primary cultures of dispersed cells of the basal hypothalamus
48. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
49. +) involves binding at the same site as the respiratory inhibitor, rotenone
50. Chronic Parkinsonism in humans due to a product of meperidine analog synthesis
51. Pargyline prevents MPTP-induced Parkinsonism in primates
52. +
53. Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism
54. Glutamate uptake by brain synaptic vesicles: energy dependence of transport and functional reconstitution in proteoliposomes
55. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
56. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
57. Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles
58. Nucleotide sequence analysis reveals similarities between proteins determining methylenomycin A resistance in streptomyces and tetracycline resistance in eubacteria
59. Effluxmediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system
60. Sequence homology between the tetracycline-resistance determinants of Tn10 and pBR322
61. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in Parkinsonian striatum by a kinetic PCR analysis
62. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter
63. Abnormalities of the electron transport chain in jdiopathic Parkinson's disease
64. Effect of deprenyl on the progression of disability in early Parkinson's disease
65. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria
66. +) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase
67. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catechalomines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells
68. Catecholamine toxicity in cerebral cortex in dissociated cell culture
69. + pumping into intracellular organelles
70. The molecular mechanism of “ecstasy” [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release
71. Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter
72. DNA sequencing with chain-terminating inhibitors
73. Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions
74. Reserpine binding to bovine chromaffin granule membranes: characterization and comparison with dihydrotetrabenazine binding
75. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure
76. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
77. Mitochondrial oxidative phosphorylation in Parkinson's disease
78. + by dopamine neurons is required for MPTP toxicity: studies in brain synaptosomes and PC-12 cells
79. Identification and purification of a functional amine transporter from bovine chromaffin granules
80. Expression of substance P/neurokinin A-encoding preprotachykinin messenger ribonucleic acids in the rat enteric nervous system
81. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action
82. Do environmental toxins cause Parkinson's disease?: a critical review
83. Cellular and molecular biology of the presynaptic nerve terminal
84. 3H]dihydrotetrabenazine-binding protein from bovine adrenal medulla
85. Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts
86. + antiporter of Escherichia coli encoded by a transposon, Tn10